DSIP is thought to increase production of GABA (20)a neurotransmitter that slows brain activity, promotes relaxation, and increases time spent in deep sleep
BPC-157 is commonly used to support individuals dealing with: Muscle strains and tears Tendon and ligament injuries Joint pain or stiffness Chronic inflammation Slow-healing or recurring injuries Post-surgical recovery support Gut issues such as bloating or irritation Overuse injuries from training or activity It is frequently chosen by athletes, active individuals, and those seeking improved recovery and digestive support
Vessel's fast-acting oral dissolving strip delivers BPC-157 in a convenient, needle-free formatbuilt for modern recovery, resilience, and performance
Each peptide has optimal timing considerations that should inform protocol design
The October 1, 2025 release applies to services through March 31, 2026
I am not convinced the data is fully there yet." Next steps Tatem said he expects the hearings to be a "hard-fought battle," but hopes committee members will consider what he described as real-world data from tens of millions of doses administered between 2014 and 2023